FDA Drug Shortage Assistance Award

Fresenius Kabi received a Drug Shortage Assistance Award from the U.S. Food and Drug Administration (FDA) on October 23rd, 2018.

The FDA recognized the role Fresenius Kabi played in helping mitigate a shortage of IV saline, specifically Sodium Chloride Injection USP, 0.9% in bags. The shortage was caused last year by supply disruptions at manufacturers affected by Hurricane Maria. The hurricane devastated Puerto Rico, where many companies produce medicines for U.S. hospitals.

Link to News Release

FDA Award Letter to Fresenius Kabi

FDA Drug Shortage Assistance Award Page